» Articles » PMID: 25689247

Gut/brain Axis and the Microbiota

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2015 Feb 18
PMID 25689247
Citations 578
Authors
Affiliations
Soon will be listed here.
Abstract

Tremendous progress has been made in characterizing the bidirectional interactions between the central nervous system, the enteric nervous system, and the gastrointestinal tract. A series of provocative preclinical studies have suggested a prominent role for the gut microbiota in these gut-brain interactions. Based on studies using rodents raised in a germ-free environment, the gut microbiota appears to influence the development of emotional behavior, stress- and pain-modulation systems, and brain neurotransmitter systems. Additionally, microbiota perturbations by probiotics and antibiotics exert modulatory effects on some of these measures in adult animals. Current evidence suggests that multiple mechanisms, including endocrine and neurocrine pathways, may be involved in gut microbiota-to-brain signaling and that the brain can in turn alter microbial composition and behavior via the autonomic nervous system. Limited information is available on how these findings may translate to healthy humans or to disease states involving the brain or the gut/brain axis. Future research needs to focus on confirming that the rodent findings are translatable to human physiology and to diseases such as irritable bowel syndrome, autism, anxiety, depression, and Parkinson's disease.

Citing Articles

The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies.

Krawczyk A, Sladowska G, Strzalka-Mrozik B Cancers (Basel). 2025; 17(5).

PMID: 40075568 PMC: 11899293. DOI: 10.3390/cancers17050719.


Heart rate variability, daily cortisol indices and their association with psychometric characteristics and gut microbiota composition in an Italian community sample.

Ravenda S, Mancabelli L, Gambetta S, Barbetti M, Turroni F, Carnevali L Sci Rep. 2025; 15(1):8584.

PMID: 40074815 PMC: 11903775. DOI: 10.1038/s41598-025-93137-8.


Tryptophan and Its Metabolite Serotonin Impact Metabolic and Mental Disorders via the Brain-Gut-Microbiome Axis: A Focus on Sex Differences.

Xu M, Zhou E, Shi H Cells. 2025; 14(5).

PMID: 40072112 PMC: 11899299. DOI: 10.3390/cells14050384.


Investigating blood-brain barrier penetration and neurotoxicity of natural products for central nervous system drug development.

Kato R, Zhang L, Kinatukara N, Huang R, Asthana A, Weber C Sci Rep. 2025; 15(1):7431.

PMID: 40032960 PMC: 11876671. DOI: 10.1038/s41598-025-90888-2.


Understanding the Impact of the Gut Microbiome on Mental Health: A Systematic Review.

Shaikh R, Dey A, Singh V, Khandagle A, M B, Naik S Cureus. 2025; 17(1):e78100.

PMID: 40018491 PMC: 11865252. DOI: 10.7759/cureus.78100.


References
1.
Collins S, Kassam Z, Bercik P . The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol. 2013; 16(3):240-5. DOI: 10.1016/j.mib.2013.06.004. View

2.
Keita A, Soderholm J . The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil. 2010; 22(7):718-33. DOI: 10.1111/j.1365-2982.2010.01498.x. View

3.
Lembo A, Camilleri M . Chronic constipation. N Engl J Med. 2003; 349(14):1360-8. DOI: 10.1056/NEJMra020995. View

4.
Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B . Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013; 144(7):1394-401, 1401.e1-4. PMC: 3839572. DOI: 10.1053/j.gastro.2013.02.043. View

5.
Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L . Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2006; 13(1):35-7. DOI: 10.1038/nm1521. View